Top compounds associated with response to UEVLD


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.093 0.02
mRNA TAK-715 GDSC1000 pan-cancer AAC -0.087 0.02
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.099 0.02
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.02
mRNA MGCD-265 CTRPv2 pan-cancer AAC -0.093 0.02
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA Doxorubicin gCSI pan-cancer AAC -0.14 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA TL-1-85 GDSC1000 pan-cancer AAC -0.078 0.02
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.091 0.02
Download CSV